- Home
- ACA vs APGE Comparison
ACA vs APGE Comparison
Compare ACA & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACA | APGE |
|---|---|---|
| Founded | 2018 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.0B |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ACA | APGE |
|---|---|---|
| Price | $104.06 | $66.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $120.00 | $101.20 |
| AVG Volume (30 Days) | 323.9K | ★ 685.0K |
| Earning Date | 05-05-2026 | 03-02-2026 |
| Dividend Yield | ★ 0.19% | N/A |
| EPS Growth | ★ 121.99 | N/A |
| EPS | ★ 4.24 | N/A |
| Revenue | ★ $2,883,400,000.00 | N/A |
| Revenue This Year | $6.26 | N/A |
| Revenue Next Year | $5.39 | N/A |
| P/E Ratio | $24.51 | ★ N/A |
| Revenue Growth | ★ 12.20 | N/A |
| 52 Week Low | $68.11 | $26.20 |
| 52 Week High | $131.00 | $84.56 |
Technical Indicators
Market Signals| Indicator | ACA | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 33.62 | 39.60 |
| Support Level | $93.23 | $66.00 |
| Resistance Level | $111.55 | $71.18 |
| Average True Range (ATR) | 4.96 | 3.87 |
| MACD | -1.05 | -0.36 |
| Stochastic Oscillator | 11.61 | 5.35 |
Price Performance
Historical ComparisonAbout ACA Arcosa Inc.
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.